Sponsor:
Mid-Atlantic Epilepsy and Sleep Center, LLC
Code:
NCT03652649
Conditions
Type2 Diabetes Mellitus
Obesity
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
3:1 ratio Ketogenic diet
Brief summary:
Conditions
Type2 Diabetes Mellitus
Obesity
Study ID
NCT03652649
Start date
Nov 1, 2017
Status verified date
Aug, 2018
Completion date
Nov 1, 2020
Anticipated
Primary completion date
Nov 1, 2020
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: 3:1 Ketogenic Complete Meal Replacement
Interventions
3:1 ratio Ketogenic diet
Primary outcome measure
Central contacts
Lenka Goldman
3015309744Locations
Ivana Tyrlikova
Recruiting
Bethesda, Maryland, United States, 20817
Contacts
Principal Investigator:
Pavel Klein, MD
Sponsor
Mid-Atlantic Epilepsy and Sleep Center, LLC
Last update posted
Aug 29, 2018
Last verified
Aug, 2018
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mid-Atlantic Epilepsy and Sleep Center, LLC on 2018-08-29.